Mr. Truitt was most recently the President and Chief Executive Officer of Achillion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company that discovers, develops, and commercializes small molecule drug therapies for immune system disorders, from 2018 to January 2020. Before serving as the President and Chief Executive Officer, Mr. Truitt served in a number of various positions at Achillion, including Executive Vice President, Chief Operations Officer (2017 to 2018) and Executive Vice President, Chief Commercial Officer (2009 to 2017). Earlier, Mr. Truitt was the Vice President, Business Development and Product Strategy of Lev Pharmaceuticals, Inc. from 2006 to 2008. He also served as Vice President, Sales and Operations of Johnson & Johnson – OraPharma, Inc. from 2000 to 2006. Prior to this, Mr. Truitt spent nine years at TAP Pharmaceuticals Inc. in a variety of sales and marketing roles before doing a two-year stint as a Consultant at IMS Health. Mr. Truitt received his B.S. in Marketing from LaSalle University and his M.B.A from St. Joseph’s University. Mr. Truitt was a Captain in the United States Marine Corps.